Catalent Inc (CTLT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John R. Chiminski
Employees:
17,300
14 SCHOOLHOUSE ROAD, SOMERSET, NJ 08873
(732) 537-6200

Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. It operates through four segments: Biologics and Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The company serves pharmaceutical, biotechnology, consumer health companies; and companies in other healthcare market segments such as animal health and medical devices.

Data derived from most recent annual or quarterly report
Market Cap 20.222 Billion Shares Outstanding179.213 Million Avg 30-day Volume 966.002 Thousand
P/E Ratio41.0385 Dividend Yield0.0 EPS0.42
Price to Revenue4.2234 Debt to Equity0.9037 EBITDA1.096 Billion
Price to Book Value4.2881 Operating Margin16.1599 Enterprise Value23.169 Billion
Current Ratio2.892 EPS Growth-0.073 Quick Ratio1.732
1 Yr BETA 1.0991 52-week High/Low 142.64 / 86.34 Profit Margin10.9292
Operating Cash Flow Growth6.9156 Altman Z-Score3.0636 Free Cash Flow to Firm -1.071 Billion
View SEC Filings from CTLT instead.

View recent insider trading info

Funds Holding CTLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTLT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-23:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    18.8 Thousand total shares from 16 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FASMAN STEVEN L EVP & CHIEF ADMIN OFFICER

    • Officer
    68,626 2022-07-26 5

    CHIMINSKI JOHN R EXECUTIVE CHAIR

    • Officer
    • Director
    169,547 2022-07-26 4

    GENNADIOS ARISTIPPOS GROUP PRES. PHARMA & CONSUMER

    • Officer
    89,721 2022-07-26 4

    MASELLI ALESSANDRO PRESIDENT & CEO

    • Officer
    • Director
    79,731 2022-07-26 2

    GUNTHER SCOTT SVP, QUALITY & REG. AFFAIRS

    • Officer
    49,941 2022-07-26 3

    ARNOLD JONATHAN SVP & CHIEF COMMERCIAL OFCR

    • Officer
    54,164 2022-07-26 6

    SCHMIDT KAY A SVP, ENTERPRISE FUNCTIONS

    • Officer
    19,417 2022-07-26 3

    PRAVDA RICARDO SVP & CHIEF HR OFFICER

    • Officer
    22,293 2022-07-26 4

    GRIPPO MICHAEL J SVP, STRATEGY & CORP. DEV.

    • Officer
    40,089 2022-07-26 4

    CASTELLANO THOMAS P SVP, CHIEF FINANCIAL OFFICER

    • Officer
    27,471 2022-07-26 3

    HOPSON RICKY PRES, CLINICAL DEV & SUPPLY

    • Officer
    37,609 2022-07-26 3

    CARLETTI LORENZO SVP GLOBAL OPS PH & CONS HLTH

    • Officer
    7,421 2022-07-26 2

    GARGIULO MARIO SVP GLOBAL OPS BIOLOGICS

    • Officer
    8,143 2022-07-26 3

    ZIPPELIUS PETER

    • Director
    4,338,292 2022-02-06 3

    WHITLOW RICCI S PRESIDENT, CSS

    • Officer
    2,923 2022-01-21 1

    FLYNN KAREN CHIEF COMMERCIAL OFFICER

    • Officer
    33,223 2022-01-10 1

    CARROLL J MARTIN

    • Director
    28,037 2021-11-29 2

    LUCIER GREGORY T

    • Director
    21,109 2021-11-23 2

    STAHL JACK L

    • Director
    32,179 2021-10-28 1

    CLASSON ROLF A

    • Director
    32,179 2021-10-28 1

    MOREL DONALD E JR

    • Director
    54,313 2021-10-28 1

    GREISCH JOHN J

    • Director
    25,731 2021-10-28 1

    CRANE ROSEMARY A

    • Director
    12,731 2021-10-28 1

    BALACHANDRAN MADHAVAN

    • Director
    16,299 2021-10-28 1

    KREUZBURG CHRISTA

    • Director
    9,330 2021-10-28 2

    BARBER MICHAEL J

    • Director
    2,247 2021-10-28 1

    JOSEPH WETTENY SVP & CHIEF FINANCIAL OFFICER

    • Officer
    49,823 2021-02-16 0

    BUZY PETER L PRESIDENT, GENE THERAPY

    • Officer
    45,950 2020-04-09 0

    LITTLEJOHNS BARRY PRESIDENT, BIOLOGICS & SDD

    • Officer
    45,882 2019-08-22 0

    HEGWOOD PAUL W JR PRESIDENT, CSS

    • Officer
    11,848 2019-08-22 0

    MIYAMOTO LANCE SVP, HUMAN RESOURCES

    • Officer
    46,799 2019-03-07 0

    DOWNIE WILLIAM SVP, GLOBAL SALES & MARKETING

    • Officer
    34,926 2019-02-15 0

    ROEHRHOFF UWE

    • Director
    16,489 2017-11-21 0

    DOLAN CHRISTINE SVP - PRODUCT DEVELOPMENT

    • Officer
    19,449 2017-08-29 0

    WALSH MATTHEW M EVP & CHIEF FINANCIAL OFFICER

    • Officer
    103,703 2017-08-24 0

    QUELLA JAMES

    • Director
    20,641 2017-08-24 0

    JOHNSON SHARON SEE REMARKS

    • Officer
    30,829 2017-04-25 0

    BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C.

    BLACKSTONE HEALTHCARE PARTNERS L.L.C.

    BLACKSTONE CAPITAL PARTNERS V L P

    BMA V L.L.C.

    BLACKSTONE HOLDINGS III L.P.

    BLACKSTONE HOLDINGS III GP L.P.

    BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.

    BLACKSTONE GROUP L.P.

    BLACKSTONE GROUP MANAGEMENT L.L.C.

    SCHWARZMAN STEPHEN A

    • 10% Owner
    No longer subject to file 2016-09-09 0

    BOOTH MELVIN D

    • Director
    16,665 2016-08-24 0

    LEONARD STEPHEN SEE REMARKS

    • Officer
    51,741 2016-07-26 0

    HOULTON SCOTT SEE REMARKS

    • Officer
    0 2015-09-02 0

    BLACKSTONE HEALTHCARE PARTNERS L.L.C.

    • 10% Owner
    40,030,960 2015-04-14 0

    KURT NIELSEN SEE REMARKS

    • Officer
    23,676 2015-02-17 0

    CHU CHINH

    • Director
    0 2014-07-31 0

    MCEVOY BRUCE

    • Director
    0 2014-07-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

    2022-07-28 19:46:30 -0400 2022-07-27 S 388 $107.67 d 17,023 direct yes -1.1494 -2.2458 0.0 1 -3.8462 4

    HOPSON RICKY - Officer PRES, CLINICAL DEV & SUPPLY

    2022-07-28 19:59:01 -0400 2022-07-27 S 591 $107.67 d 17,095 direct yes -1.1494 -2.2458 0.0 1 -3.8462 4

    GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

    2022-07-28 19:58:31 -0400 2022-07-27 S 394 $107.67 d 22,350 direct yes -1.1494 -2.2458 0.0 1 -3.8462 4

    GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

    2022-07-28 19:46:30 -0400 2022-07-26 S 409 $106.90 d 16,110 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GENNADIOS ARISTIPPOS - Officer GROUP PRES. PHARMA & CONSUMER

    2022-07-28 19:45:05 -0400 2022-07-26 A 8,078 a 8,078 direct

    GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

    2022-07-28 19:46:30 -0400 2022-07-26 A 1,301 a 17,411 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

    2022-07-28 19:46:30 -0400 2022-07-26 A 5,655 a 5,655 direct

    HOPSON RICKY - Officer PRES, CLINICAL DEV & SUPPLY

    2022-07-28 19:59:01 -0400 2022-07-26 S 312 $106.90 d 17,035 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    HOPSON RICKY - Officer PRES, CLINICAL DEV & SUPPLY

    2022-07-28 19:59:01 -0400 2022-07-26 A 651 a 17,686 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    HOPSON RICKY - Officer PRES, CLINICAL DEV & SUPPLY

    2022-07-28 19:59:01 -0400 2022-07-26 A 2,828 a 2,828 direct

    GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

    2022-07-28 19:58:31 -0400 2022-07-26 S 450 $106.90 d 21,629 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

    2022-07-28 19:58:31 -0400 2022-07-26 A 1,115 a 22,744 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

    2022-07-28 19:58:31 -0400 2022-07-26 A 4,847 a 4,847 direct

    MASELLI ALESSANDRO - Director - Officer PRESIDENT & CEO

    2022-07-28 20:00:15 -0400 2022-07-26 S 816 $106.90 d 25,083 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    MASELLI ALESSANDRO - Director - Officer PRESIDENT & CEO

    2022-07-28 20:00:15 -0400 2022-07-26 A 10,221 a 35,304 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    MASELLI ALESSANDRO - Director - Officer PRESIDENT & CEO

    2022-07-28 20:00:15 -0400 2022-07-26 A 44,427 a 44,427 direct

    PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

    2022-07-28 20:01:27 -0400 2022-07-26 S 427 $106.90 d 15,337 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

    2022-07-28 20:01:27 -0400 2022-07-26 A 1,301 a 16,638 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

    2022-07-28 20:01:27 -0400 2022-07-26 A 5,655 a 5,655 direct

    SCHMIDT KAY A - Officer SVP, ENTERPRISE FUNCTIONS

    2022-07-28 20:03:51 -0400 2022-07-26 S 323 $106.90 d 13,455 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    SCHMIDT KAY A - Officer SVP, ENTERPRISE FUNCTIONS

    2022-07-28 20:03:51 -0400 2022-07-26 A 1,115 a 14,570 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    SCHMIDT KAY A - Officer SVP, ENTERPRISE FUNCTIONS

    2022-07-28 20:03:51 -0400 2022-07-26 A 4,847 a 4,847 direct

    GENNADIOS ARISTIPPOS - Officer GROUP PRES. PHARMA & CONSUMER

    2022-07-28 19:45:05 -0400 2022-07-26 A 1,859 a 81,643 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    ARNOLD JONATHAN - Officer SVP & CHIEF COMMERCIAL OFCR

    2022-07-28 19:35:32 -0400 2022-07-26 S 94 $106.90 d 48,698 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    ARNOLD JONATHAN - Officer SVP & CHIEF COMMERCIAL OFCR

    2022-07-28 19:35:32 -0400 2022-07-26 A 1,023 a 49,721 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    ARNOLD JONATHAN - Officer SVP & CHIEF COMMERCIAL OFCR

    2022-07-28 19:35:32 -0400 2022-07-26 A 4,443 a 4,443 direct

    CARLETTI LORENZO - Officer SVP GLOBAL OPS PH & CONS HLTH

    2022-07-28 19:39:31 -0400 2022-07-26 S 631 $106.90 d 2,949 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    CARLETTI LORENZO - Officer SVP GLOBAL OPS PH & CONS HLTH

    2022-07-28 19:39:31 -0400 2022-07-26 A 837 a 3,786 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    CARLETTI LORENZO - Officer SVP GLOBAL OPS PH & CONS HLTH

    2022-07-28 19:39:31 -0400 2022-07-26 A 3,635 a 3,635 direct

    CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

    2022-07-28 19:39:50 -0400 2022-07-26 S 347 $106.90 d 15,051 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

    2022-07-28 19:39:50 -0400 2022-07-26 A 2,323 a 17,374 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

    2022-07-28 19:39:50 -0400 2022-07-26 A 10,097 a 10,097 direct

    CHIMINSKI JOHN R - Director - Officer EXECUTIVE CHAIR

    2022-07-28 19:41:39 -0400 2022-07-26 S 9,691 $106.90 d 132,382 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    CHIMINSKI JOHN R - Director - Officer EXECUTIVE CHAIR

    2022-07-28 19:41:39 -0400 2022-07-26 A 37,165 a 169,547 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GARGIULO MARIO - Officer SVP GLOBAL OPS BIOLOGICS

    2022-07-28 19:43:57 -0400 2022-07-26 S 969 $106.90 d 3,671 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GARGIULO MARIO - Officer SVP GLOBAL OPS BIOLOGICS

    2022-07-28 19:43:57 -0400 2022-07-26 A 837 a 4,508 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    GARGIULO MARIO - Officer SVP GLOBAL OPS BIOLOGICS

    2022-07-28 19:43:57 -0400 2022-07-26 A 3,635 a 3,635 direct

    FASMAN STEVEN L - Officer EVP & CHIEF ADMIN OFFICER

    2022-07-28 19:42:48 -0400 2022-07-26 S 2,546 $106.90 d 53,721 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    FASMAN STEVEN L - Officer EVP & CHIEF ADMIN OFFICER

    2022-07-28 19:42:48 -0400 2022-07-26 A 2,788 a 56,509 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    FASMAN STEVEN L - Officer EVP & CHIEF ADMIN OFFICER

    2022-07-28 19:42:48 -0400 2022-07-26 A 12,117 a 12,117 direct

    GENNADIOS ARISTIPPOS - Officer GROUP PRES. PHARMA & CONSUMER

    2022-07-28 19:45:05 -0400 2022-07-26 S 403 $106.90 d 79,784 direct -1.1494 -2.2458 0.0 1 -3.8462 4

    ARNOLD JONATHAN - Officer SVP & CHIEF COMMERCIAL OFCR

    2022-07-05 17:46:08 -0400 2022-07-01 A 2,804 $107.02 a 48,792 direct 1.6575 -5.0458 2.3901 3 -5.0458 6

    GENNADIOS ARISTIPPOS - Officer GROUP PRES. PHARMA & CONSUMER

    2022-07-05 17:46:24 -0400 2022-07-01 A 18,689 $107.02 a 80,187 direct 1.6575 -5.0458 2.3901 3 -5.0458 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CATALENT INC CTLT 2022-08-11 22:15:03 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 21:45:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 21:15:03 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 20:45:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 20:15:03 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 19:45:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 19:15:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 18:45:03 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 18:15:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 17:45:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 17:15:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 16:45:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 16:15:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 15:45:05 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 15:15:03 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 14:45:06 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 14:15:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 13:45:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 13:15:04 UTC 2.07 0.25 7100000
    CATALENT INC CTLT 2022-08-11 12:45:04 UTC 2.07 0.25 7100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund CTLT -1986.0 shares, $-111811.8 2019-12-31 N-PORT
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund CTLT -1742.0 shares, $-98074.6 2019-12-31 N-PORT
    American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund CTLT -7587.0 shares, $-361596.42 2019-09-30 N-PORT
    American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund CTLT -24803.0 shares, $-1182110.98 2019-09-30 N-PORT
    FundVantage Trust- Gotham Enhanced Index Plus Fund CTLT -68.0 shares, $-3532.6 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund CTLT -105.0 shares, $-5454.75 2020-03-31 N-PORT
    AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund CTLT -867.0 shares, $-41321.22 2019-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund CTLT -127.0 shares, $-6597.65 2020-03-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund CTLT -178.0 shares, $-18745.18 2021-03-31 N-PORT
    JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund CTLT -1109.0 shares, $-116788.79 2021-03-31 N-PORT
    FundVantage Trust- Gotham Hedged Core Fund CTLT -342.0 shares, $-37927.8 2022-03-31 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund CTLT -37.0 shares, $-4103.3 2022-03-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund CTLT -135.0 shares, $-14971.5 2022-03-31 N-PORT
    Legg Mason Global Asset Management Trust- Franklin Global Market Neutral Fund CTLT -2300.0 shares, $-255070.0 2022-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund CTLT -645.0 shares, $-71530.5 2022-03-31 N-PORT
    Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund CTLT -1800.0 shares, $-199620.0 2022-03-31 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund CTLT -657.0 shares, $-72861.3 2022-03-31 N-PORT
    TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund CTLT -412.0 shares, $-45690.8 2022-03-31 N-PORT
    CRM Mutual Fund Trust- CRM LONG/SHORT OPPORTUNITIES CTLT -8925.0 shares, $-989782.5 2022-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CTLT -2200.0 shares, $-243980.0 2022-03-31 N-PORT
    Steward Funds Inc- Steward Equity Market Neutral Fund CTLT -500.0 shares, $-45280.0 2022-04-29 N-PORT
    Principal Funds, Inc- Global Multi-Strategy Fund CTLT 2779.0 shares, $-286403.74 2022-05-31 N-PORT
    GMO TRUST- GMO Strategic Opportunities Allocation Fund CTLT -2200.0 shares, $-226732.0 2022-05-31 N-PORT
    GMO TRUST- GMO Benchmark-Free Fund CTLT -15100.0 shares, $-1556206.0 2022-05-31 N-PORT
    GMO TRUST- GMO Implementation Fund CTLT -42300.0 shares, $-4359438.0 2022-05-31 N-PORT
    GMO TRUST- GMO Alternative Allocation Fund CTLT -2600.0 shares, $-267956.0 2022-05-31 N-PORT
    Nuveen Investment Trust II- Nuveen Equity Long/Short Fund CTLT -3800.0 shares, $-391628.0 2022-05-31 N-PORT

    Elevate your investments